543
Participants
Start Date
May 12, 2020
Primary Completion Date
March 26, 2021
Study Completion Date
April 21, 2021
SAGE-217
SAGE-217 oral capsules.
Placebo
SAGE-217 matched-placebo oral capsules.
Sage Investigational Site, Allentown
Sage Investigational Site, Charlottesville
Sage Investigational Site, Charlotte
Sage Investigational Site, Charleston
Sage Investigational Site, Alpharetta
Sage Investigational Site, Decatur
Sage Investigational Site, Atlanta
Sage Investigational Site, Atlanta
Sage Investigational Site, Jacksonville
Sage Investigational Site, Orange City
Sage Investigational Site, Orlando
Sage Investigational Site, Orlando
Sage Investigational Site, Hollywood
Sage Investigational Site, Coral Springs
Sage Investigational Site, Lauderhill
Sage Investigational Site, Memphis
Sage Investigational Site, Flowood
Sage Investigational Site, North Canton
Sage Investigational Site, Cincinnati
Sage Investigational Site, Dayton
Sage Investigational Site, Skokie
Sage Investigational Site, O'Fallon
Sage Investigational Site, Rogers
Sage Investigational Site, Oklahoma City
Sage Investigational Site, DeSoto
Sage Investigational Site, Wichita Falls
Sage Investigational Site, Las Vegas
Sage Investigational Site, Pico Rivera
Sage Investigational Site, Bellflower
Sage Investigational Site, Glendale
Sage Investigational Site, Sherman Oaks
Sage Investigational Site, Lemon Grove
Sage Investigational Site, San Diego
Sage Investigational Site, Redlands
Sage Investigational Site, Temecula
Sage Investigational Site, Garden Grove
Sage Investigational Site, Orange
Sage Investigational Site, Portland
Sage Investigational Site, Marlton
Lead Sponsor
Biogen
INDUSTRY